The Discounted Cash Flow (DCF) valuation of Theradiag SA (ALTER.PA) is (2.28) EUR. With the latest stock price at 1.26 EUR, the upside of Theradiag SA based on DCF is -280.7%.
Based on the latest price of 1.26 EUR and our DCF valuation, Theradiag SA (ALTER.PA) is a sell. selling ALTER.PA stocks now will result in a potential gain of 280.7%.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| WACC / Discount Rate | 4.9% - 6.4% | 5.7% |
| Long-term Growth Rate | 3.0% - 4.6% | 3.8% |
| Fair Price | (18.28) - (1.10) | (2.28) |
| Upside | -1551.1% - -187.7% | -280.7% |